The trial is taking place at:
A

Arizona Research Center | Phoenix, AZ

Veeva-enabled site

A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears

I

InGeneron

Status

Invitation-only

Conditions

Partial Thickness Rotator Cuff Tear

Treatments

Device: Corticosteroid
Device: Adipose Derived Regenerative Cells

Study type

Interventional

Funder types

Industry

Identifiers

NCT05400798
RC-004

Details and patient eligibility

About

This is a longitudinal follow-up study of the RC-002 study, in which up to 246 subjects assigned to two randomization arms will be enrolled: an adipose-derived regenerative cell (ADRC) injection arm (ADRC treatment arm) and the SOC corticosteroid injection arm (active control arm). All subjects will be randomly assigned to ADRC treatment or active control arms in a 2:1 ratio and will be followed up for 6 months. The goal of the RC-004 study is to enroll all patients that were enrolled and treated in RC-002 and follow for 3 years.

Enrollment

246 estimated patients

Sex

All

Ages

30 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 1. Subjects must have completed RC-002.
  • 2. Subjects can give appropriate consent.

Exclusion criteria

  • 1. Subjects who require the use of index arm for ambulation or mobilization via wheelchair, walker, crutches or cane.
  • 2. Subjects whose pain behavior or pain medication usage is, in the opinion of the Investigator, out of proportion to the underlying clinical condition or could interfere with the study-required assessments.
  • 3. Subject is on an active regimen of chemotherapy or radiation-based treatment.
  • 4. Subject is part of a vulnerable population who, in the judgment of the Investigator, is unable to give informed consent for reasons of incapacity, immaturity, adverse personal circumstances or lack of autonomy. This may include individuals with a mental disability, persons in nursing homes, children, impoverished persons, persons in emergency situations, homeless persons, nomads, refugees, and those incapable of giving informed consent. Vulnerable populations also may include members of a group with a hierarchical structure such as university students, subordinate hospital and laboratory personnel, employees of the Sponsor, members of the armed forces, and persons kept in detention.
  • 5. Uncooperative subjects or those with neurological/psychiatric disorders who are incapable of following directions or who are predictably unwilling to return for follow-up examinations.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

246 participants in 2 patient groups

Adipose Derived Regenerative Cells
Experimental group
Description:
a single injection of adipose-derived regenerative cells (ADRCs) into the partial-thickness rotator cuff tear
Treatment:
Device: Adipose Derived Regenerative Cells
Corticosteroid
Active Comparator group
Description:
a single corticosteroid injection into the subacromial space of the index arm
Treatment:
Device: Corticosteroid

Trial contacts and locations

11

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems